Schizophrenia Clinical Trial
Official title:
Discussion on the Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia Based on the Theory of "Heart Dominating Mind" and "Body-spirit Syncretism" in Traditional Chinese Medicine
NCT number | NCT05310955 |
Other study ID # | YSF2021-59 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 16, 2022 |
Est. completion date | June 2023 |
The purpose of this study is to observe the intervention effect of shen-based Qigong exercise on residual symptoms of schizophrenia.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | June 2023 |
Est. primary completion date | June 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Han Chinese population 2. age = 18 years 3. education level = 6 years, can fill in the questionnaire independently, have enough audio-visual level to complete the necessary examination 4. assessed by MINI 7.0 and satisfied with the diagnostic criteria for schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fifth edition(DSM-5) 5. patients with schizophrenia residing in the rehabilitation ward, without relapse in the past 6 months 6. residual negative symptoms, with at least one item = 2 on the negative subscale of PANSS (N1-N7) 7. taking second generation antipsychotics 8. no training history of traditional Chinese exercises 9. agreement to participate in the study and willing to give written informed consent Exclusion Criteria: 1. having severe physical diseases such as cardiovascular, lung, liver, kidney, and hematopoietic diseases 2. satisfied with the diagnostic criteria for other mental disorders based on DSM-5 3. having alcohol or substance abuse/dependence 4. having mental retardation(WAIS<70) and/or severe cognitive impairment(MMSE<24) 5. having visual and / or hearing problems, unable to complete the relevant test 6. electroconvulsive or repetitive transcranial magnetic stimulation(rTMS) therapy in the past 3 months 7. currently enrolled or participated in other clinical studies in the past 3 months 8. participating in regular exercise training in the past 6 months 9. failure to sign or refuse to sign informed consent |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Mental Health Center | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Mental Health Center | Shanghai University of Traditional Chinese Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | change of n-back task | Specific cognitive domain--working memory will be assessed by n-back task. N-back task paradigm is the most classical paradigm in working memory research. | Change from Baseline at 3 months | |
Other | change of 36-item Short Form Health Survey(SF-36) | 36-item Short Form Health Survey(SF-36)will be used to assess the health-related quality of life of patients. SF-36 is one of the most commonly used standardized measurement tools for quality of life in the world, including eight subscales, a total of 36 items, involving physical and mental health. | Change from Baseline at 3 months | |
Other | change of Social-Adaptive Functioning Evaluation (SAFE) | Social functions will be assessed using Social-Adaptive Functioning Evaluation (SAFE). SAFE can evaluate the social adaptation function of patients with mental disorders over 18 years old. It has a total of 19 items, divided into basic life skills, advanced life skills, social skills and communication skills in four areas; each item 0-4 score, the higher the score, the more serious the damage. | Change from Baseline at 3 months | |
Other | change of the Scale for the Assessment of Positive Symptoms (SAPS) | Positive symptoms will be evaluated using the Scale for the Assessment of Positive Symptoms (SAPS). SAPS measures positive symptoms on a 34 item, 6-point scale, a total of 170 points. Items are listed under hallucinations, delusions, bizarre behavior, and positive formal thought disorder. | Change from Baseline at 3 months | |
Other | change of heart rate variability (HRV) | Heart rate variability (HRV) will be used as the evaluation index for cardiac function. HRV is a widely used non-invasive tool for evaluating cardiac autonomic nerve function. | Change from Baseline at 3 months | |
Other | change of height | Height will be measured using a height ruler, expressed in meters. | Change from Baseline at 3 months | |
Other | change of weight | Weight will be measured using a weighting scale, expressed in kilograms. | Change from Baseline at 3 months | |
Other | change of waistline | Waistline will be measured using a flexible rule, expressed in centimeters. | Change from Baseline at 3 months | |
Other | change of blood pressure | Blood pressure will be measured using a sphygmomanometer, expressed in millimeter of mercury. | Change from Baseline at 3 months | |
Other | change of gait data | Acquire gait data in a quiet, well-lit room. Specify the walking area to guide the participants to complete the walking cycle. | Change from Baseline at 3 months | |
Primary | change of the Scale for the Assessment of Negative Symptoms (SANS) | Negative symptoms will be evaluated using the Scale for the Assessment of Negative Symptoms (SANS). The scale made up for the lack of attention to negative symptoms in previous psychiatric rating scales. It contains five subscales: affective blunting, alogia, avolition/apathy, anhedonia/asociality, and attention. A total of 24 items were scored at 6 levels for each item. | Change from Baseline at 3 months | |
Secondary | change of Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | RBANS will be used to assess global cognitive function. RBANS yields scaled scores for 5 cognitive domains and shows a good effect in cognitive assessment of patients with schizophrenia. | Change from Baseline at 3 months | |
Secondary | change of event-related potential P300 (ERP P300) | ERP P300 will be used to assess global cognitive function. ERP P300 is an endogenous cognitive component related to high-level psychological activities such as attention, memory, feeling, learning and reasoning. It has good stability and can reflect the level of cognitive function from different aspects. | Change from Baseline at 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |